These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 872136)

  • 1. CIS-Dichlorodiammineplatinum(II) in the treatment of epidermoid carcinoma of the head and neck.
    Wittes RE; Cvitkovic E; Shah J; Gerold FP; Strong EW
    Cancer Treat Rep; 1977; 61(3):359-66. PubMed ID: 872136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors].
    Zamboglou N; Pape H; Schnabel T; Wurm R; Bannach B; Fürst G; Schmitt G
    Strahlenther Onkol; 1989 Sep; 165(9):647-51. PubMed ID: 2678546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cis-dichlorodiammineplatinum(II), methotrexate, bleomycin, and vincristine in head and neck cancer: a pilot study.
    King GW; Halpin JJ; Smith RE; Batley F; Schuller DE
    Cancer Treat Rep; 1979; 63(11-12):1735-8. PubMed ID: 93508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
    Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
    Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
    Papadimitrakopoulou VA; Dimery IW; Lee JJ; Perez C; Hong WK; Lippman SM
    Cancer J Sci Am; 1997; 3(2):92-9. PubMed ID: 9099459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.
    Choi YJ; Chung JS; Shin HJ; Cho GJ; Wang SG; Lee BJ; Cho BM; Joo YD; Sohn CH
    J Laryngol Otol; 2008 Aug; 122(8):848-53. PubMed ID: 18047761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
    Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Hong WK; Lippman SM
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):40-4; discussion 45-8. PubMed ID: 9578061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose cisplatin with fluid and mannitol-induced diuresis in advanced lung cancer: a phase II clinical trial of the EORTC Lung Cancer Working Party (Belgium).
    De Jager R; Longeval E; Klastersky J
    Cancer Treat Rep; 1980; 64(12):1341-6. PubMed ID: 6258791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cis-Dichlorodiammineplatinum (II) in advanced osteogenic sarcoma.
    Ochs JJ; Freeman AI; Douglass HO; Higby DS; Mindell ER; Sinks LF
    Cancer Treat Rep; 1978 Feb; 62(2):239-45. PubMed ID: 346212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combination chemotherapy with cis-diammine-di-chloro-platinum (II) and bleomycin in advanced head and neck cancer].
    Sasaki T; Ibuka T; Imai K; Sakai Y; Hayakawa M; Tanikawa Y; Miyashita H; Komiya Y; Matsuda T
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1412-7. PubMed ID: 6191715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate, bleomycin, and high-dose-cis-dichlorodiammineplatinum(II) in the treatment of advanced epidermoid carcinoma of the head and neck.
    Caradonna R; Paladine W; Ruckdeschel JC; Goldstein JC; Olson JE; Jaski JW; Silvers SA; Hillinger S; Horton J
    Cancer Treat Rep; 1979 Mar; 63(3):489-91. PubMed ID: 85494
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase I study of high-dose cis-dichlorodiammineplatinum(II) with forced diuresis.
    Chary KK; Higby DJ; Henderson ES; Swinerton KD
    Cancer Treat Rep; 1977; 61(3):367-70. PubMed ID: 266972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cis-dichlorodiammineplatinum(II) in advanced bladder cancer.
    Yagoda A; Watson RC; Gonzalez-Vitale JC; Grabstald H; Whitmore WF
    Cancer Treat Rep; 1976 Jul; 60(7):917-23. PubMed ID: 1009522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cis-Dichlorodiammineplatinum(II)-based chemotherapy as initial treatment of advanced head and neck cancer.
    Wittes R; Heller K; Randolph V; Howard J; Vallejo A; Farr H; Harrold C; Gerold F; Shah J; Spiro R; Strong E
    Cancer Treat Rep; 1979; 63(9-10):1533-8. PubMed ID: 498153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cis-Dichlorodiammineplatinum(II) in the treatment of esophageal carcinoma.
    Davis S; Shanmugathasa M; Kessler W
    Cancer Treat Rep; 1980; 64(4-5):709-11. PubMed ID: 7191780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platinum analogs in recurrent and advanced head and neck cancer: a Southwest Oncology Group and Wayne State University Study.
    Al-Sarraf M; Metch B; Kish J; Ensley J; Rinehart JJ; Schuller DE; Coltman CA
    Cancer Treat Rep; 1987; 71(7-8):723-6. PubMed ID: 3300967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck.
    Kish J; Drelichman A; Jacobs J; Hoschner J; Kinzie J; Loh J; Weaver A; Al-Sarraf M
    Cancer Treat Rep; 1982 Mar; 66(3):471-4. PubMed ID: 7037180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of cis-dichlorodiammineplatinum(II) in advanced malignant lymphoma and small cell lung cancer: preliminary results.
    Cavalli F; Jungi WF; Sonntag RW; Nissen NI; Holland JF
    Cancer Treat Rep; 1979; 63(9-10):1599-603. PubMed ID: 227599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cis-Dichlorodiammineplatinum(II) for the treatment of advanced ovarian cancer.
    Young RC; Von Hoff DD; Gormley P; Makuch R; Cassidy J; Howser D; Bull JM
    Cancer Treat Rep; 1979; 63(9-10):1539-44. PubMed ID: 387224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.